SCHEMBL24252400

SCHEMBL24252400

COc1ccc(CNc2nnc(C)c3cc(-c4cc(B5OC(C)(C)C(C)(C)O5)ccc4OCCOCCOCCNC(=O)OC(C)(C)C)ccc23)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
BCHE P06276 3/20 0.36
CNR2 P34972 3/20 0.36
CYP1A2 P05177 7/20 0.35
CYP3A4 P08684 7/20 0.35
CYP2C19 P33261 7/20 0.35
ALDH1A1 P00352 5/20 0.35
CLK4 Q9HAZ1 4/20 0.35
HSD17B10 Q99714 4/20 0.35
CYP2C9 P11712 4/20 0.35
TSHR P16473 4/20 0.35
LMNA P02545 3/20 0.35
CYP2D6 P10635 6/20 0.34
MAPK1 P28482 5/20 0.34
USP2 O75604 4/20 0.34
MAPT P10636 1/20 0.34
HIF1A Q16665 1/20 0.34
KDM4E B2RXH2 2/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30467688 1.00 PRMT5 (0.38) PRMT5WDR77BCHECNR2CYP1A2
SCHEMBL25248371 0.88 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL30467568 0.88 CYP1A2 (0.38) BCHECNR2CYP1A2CYP3A4CYP2C19
SCHEMBL24252850 0.88 CYP1A2 (0.38) BCHECNR2CYP1A2CYP3A4CYP2C19
SCHEMBL25212977 0.86 CYP1A2 (0.37) BCHECNR2CYP1A2CYP3A4CYP2C19
SCHEMBL31753942 0.86 CYP1A2 (0.37) BCHECNR2CYP1A2CYP3A4CYP2C19
SCHEMBL30467817 0.86 PRMT5 (0.37) PRMT5WDR77BCHECNR2CYP1A2
SCHEMBL30467599 0.86 PRMT5 (0.37) PRMT5WDR77BCHECNR2CYP1A2
SCHEMBL26781139 0.86 PRMT5 (0.37) PRMT5WDR77BCHECNR2CYP1A2
SCHEMBL24252325 0.86 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 PRMT5 2513/4885WDR77 2935/4885BCHE 101/4885
US-11814404-B2 Inhibitors of complement factors and uses thereof CFB, CFH, C9 PRMT5 2513/4885WDR77 2935/4885BCHE 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.